Eli Lilly SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedEli Lilly Q3 2026 non-GAAP EPS $7.48 beats $6.61 consensus on $24.4 billion revenue; raises 2026 revenue guidance to $91.0-$92.0 billion
Results of operations and financial condition · Financial statements and exhibits